Navigation Links
Cancer Drug Banned in England

Cancer drug Velcade has been banned in England because the Government’s drugs rationing watchdog, National Institute for Health and Clinical Excellence (NICE) has refused// to fund treatment, according to last night’s claims.

NICE has planned to announce next week that Velcade should not be offered on the NHS to treat multiple myeloma, a cancer of the bone marrow. Presently a course of Velcade has been estimated to cost between £9,000 and £18,000 and was already approved for use in Scotland in 1994.

Cancer sufferers and cancer charities criticized the decision by NICE, saying this was their latest attempt saving the Government money by rejecting drugs that increase life expectancy. Since June, NICE has refused to endorse five treatments including treatment for bowel cancer, leukaemia and breast cancer, as well as Alzheimer’s disease that would grant an extension to peoples’ lives suffering from these diseases.

As one cancer sufferer said: “Are they saying a Scottish life is worth more than an English life? “They are effectively saying to people with incurable diseases, ‘sit down in a darkened room and die’.”

NICE has refused to comment on next week’s announcement. A NICE spokesman said: “NICE’s expert advisers review all the evidence on cancer treatments to determine whether they add benefits for patients when compared to other treatments that are already available.

“The benefits that we assess include whether a drug extends life, and whether a drug improves patients’ quality of life.”

A Department of Health spokesman has refused to comment until the guidance was published.

SourceMedindia
NLA
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... Techniques.” The guide will ensure lab personnel have a basic understanding of the ... lab measurement protocols. Enhanced understanding will help them reduce waste and rework to ...
(Date:2/9/2016)... California (PRWEB) , ... February 09, 2016 , ... i2i ... one of the highest preliminary data vendors in the latest KLAS report, Population Health ... i2i has led the developing market for population health management (PHM). The latest ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... with BASF Human Nutrition into the Food & Beverage and ... been BASF’s channel partner throughout Canada and USA geographies east of the Rocky ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenton Engineering , powered ... and flow wrapped products at WestPack 2015, February 9-11, in Anaheim, California. This ... to semi-automatic or fully-automatic case packing with a small footprint, rugged, highly flexible, ...
(Date:2/8/2016)... ... 08, 2016 , ... Local insurance agency Dennis Fuller & ... has initiated a fundraiser for a two year old little girl named Bella, ... To support this beautiful child who is facing life’s journey without her loving ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... new report "Global Anti-Bacterial Drugs Market Assessment & Forecast: 2015 - ... the North America continued to lead global ... translated into revenues worth US$ 16,907.3 million. ... Asia-Pacific , Latin America , ... anti-bacterial market is inclined towards North America ...
(Date:2/8/2016)... -- Respiratory Devices - Medical Devices Pipeline Assessment, ... report, " Respiratory Devices - Medical Devices Pipeline ... Devices currently in pipeline stage. The report ... comparative analysis of the products at various stages ... in the pipeline product development. It also provides ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology: